Fresh off of a successful IPO, Avalyn Pharma CEO Lyn Baranowski describes the company's inhaled medicines platform, and shares her secrets to success as a leader episode artwork

EPISODE · Jul 23, 2026 · 21 MIN

Fresh off of a successful IPO, Avalyn Pharma CEO Lyn Baranowski describes the company's inhaled medicines platform, and shares her secrets to success as a leader

from Biotech CEO Sisterhood · host BiotechTV

Interviewed by Sisterhood editorial board member Erika Smith, Lyn Baranowski highlights the company's $345 million IPO, which enables it to further develop its inhaled medicines. She describes why they believe this delivery method provides a more direct and efficient way to treat fibrotic lung conditions like IPF.

Episode metadata supplied by the publisher feed · Published Jul 23, 2026

Embed this episode

Ready to play

Fresh off of a successful IPO, Avalyn Pharma CEO Lyn Baranowski describes the company's inhaled medicines platform, and shares her secrets to success as a leader

0:00 21:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biotech CEO Sisterhood?

This episode is 21 minutes long.

When was this Biotech CEO Sisterhood episode published?

This episode was published on July 23, 2026.

Can I download this Biotech CEO Sisterhood episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!